Berenberg Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold
Berenberg analyst Kerry Holford downgraded Novo Nordisk (NOVOB:DC) (NYSE: NVO) from Buy to Hold with a price target of DKK305.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
